Sort
40,608 grants matching “prostate cancer”
DETERMINANTS OF ESTRAMUSTINE RESISTANCE AND RESPONSE
$387,578Fox Chase Cancer Center · R01 · FY2001 · CA
Transrectal Prostate Therapy Robot in Closed MRI Scanner
$387,569Louis Litchfield Whitcomb · Johns Hopkins University · R01 · FY2007 · EB
Clinical Radiation Physics Service
$387,559Robert Miller · Division Of Clinical Sciences - Nci · ZID · FY2023 · CA
Baylor College of Medicine Cancer Center
$387,538Baylor College Of Medicine · P20 · FY2004 · CA
Aberrant Splice Variants as Potential Precision Biomarkers for Aggressive Prostate Cancers in African American Patients
$387,500Bi-Dar Wang · University Of Maryland Eastern Shore · SC1 · FY2022 · GM
Aberrant Splice Variants as Potential Precision Biomarkers for Aggressive Prostate Cancers in African American Patients
$387,500Bi-Dar Wang · University Of Maryland Eastern Shore · SC1 · FY2021 · GM
Aberrant Splice Variants as Potential Precision Biomarkers for Aggressive Prostate Cancers in African American Patients
$387,500Bi-Dar Wang · University Of Maryland Eastern Shore · SC1 · FY2020 · GM
Aberrant Splice Variants as Potential Precision Biomarkers for Aggressive Prostate Cancers in African American Patients
$387,500Bi-Dar Wang · University Of Maryland Eastern Shore · SC1 · FY2019 · GM
TRANSGENIC MOUSE MODEL FOR PROSTATE CANCER
$387,477Vanderbilt University · R01 · FY2002 · CA
Validating the performance and inclusivity of a novel functionally-informed predictive genetic test method for polygenic disease
$387,472Tejal Patwardhan · Martingale Labs, Inc. · R43 · FY2023 · HG
DISCOVERY AND CHARACTERIZATION OF PRCAT47: A NOVEL PROSTATE LINEAGE AND CANCER-SPECIFIC LONG NONCODING RNA
$387,438Regents Of The University Of Michigan · · FY2016 · Department of the Army
DEVELOPMENT OF MULTIPARAMETRIC MRI MODEL OF CLINICALLY SIGNIFICANT PROSTATE CANCER
$387,419Regents Of The University Of Minnesota · · FY2015 · Department of the Army
Rel B mediated-redox regulation of radiation therapy
$387,406Daret K St Clair · University Of Kentucky · R01 · FY2012 · CA
Integrin alpha6beta4 Signaling in Prostate Carcinoma Growth and Invasion
$387,389Filippo G Giancotti · Sloan-Kettering Inst Can Research · R01 · FY2006 · CA
Molecular and Computational Tools for Identifying Somatic Mosaicism in Human Tissues
$387,347Ryan E Mills · University Of Michigan At Ann Arbor · UG3 · FY2024 · NS
MR GUIDED FOCUSED ULTRASOUND ABLATION OF PROSTATE CANCER
$387,339General Electric Global Research Ctr · R33 · FY2003 · CA
Trk Expression and Inhibition in Human Neuroblastomas
$387,333Garrett M Brodeur · Children'S Hosp Of Philadelphia · R01 · FY2010 · CA
Project 2: Integrating a Novel MiPS-Based Next-Generation Sequencing Urine Assay for the Early Detection of Unfavorable Risk Prostate Cancer
$387,257Ganesh S Palapattu · University Of Michigan At Ann Arbor · P50 · FY2023 · CA
Therapeutic targeting steroid sulfatase for advanced prostate cancer
$387,245Allen C Gao · University Of California At Davis · R01 · FY2020 · CA
Advanced development and validation of genome-scale molecular diagnostics for microsatelliteinstability using targeted molecular counting methods
$387,195Stephen J Salipante · University Of Washington · R33 · FY2020 · CA
Role of PALB2 in the DNA Damage Response and Cancer Suppression
$387,173Bing Xia · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA
Community Outreach and Engagement
$387,140Laura Fejerman · University Of California At Davis · P30 · FY2024 · CA
Lineage-specific signaling and targeting of PI3K gamma in myeloid malignancies
$387,128Kris C. Wood · Duke University · R01 · FY2024 · CA
Mitochondrial and nuclear functions of NKX3.1 in regulating oxidative stress in prostate cancer
$387,084Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2020 · CA
Mitochondrial and nuclear functions of NKX3.1 in regulating oxidative stress in prostate cancer
$387,084Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2019 · CA